Results 161 to 170 of about 548,348 (332)

Screening for lung cancer: A systematic review of overdiagnosis and its implications

open access: yesMolecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz   +12 more
wiley   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Physicians' Practice of Dispensing Medicines: A Qualitative Study [PDF]

open access: yes, 2014
Objectives: The physical act of giving medication to patients to administer away from a health care setting, dispensing, is normally performed by pharmacists. Dispensing of medication by physicians is a neglected patient safety issue, and having observed
Baker, Paul   +3 more
core  

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

open access: yesMolecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He   +8 more
wiley   +1 more source

Investigation of the Causes of Medication Errors and Not Reporting it in Nurses of the Shahid Beheshti Hospital of Qom City, 2017, (Iran)

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, 2019
Background and Objectives: Medication errors can cause serious problems in health systems and is considered as a threat for patient safety. The purpose of this study was to investigate the types and causes of medication errors as well as their non ...
Alireza Amiri Mehra   +4 more
doaj  

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

open access: yesMolecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia   +9 more
wiley   +1 more source

Introducing Unit Dose Dispensing in a University Hospital – Effects on Medication Safety and Dispensing Time

open access: yesRisk Management and Healthcare Policy
Hanne Katriina Ahtiainen,1,2 Carita Lindén-Lahti,1,2 Susanna Heininen,1 Anna-Riia Holmström,1 Lotta Schepel2,3 1Faculty of Pharmacy, University of Helsinki, Helsinki, Finland; 2HUS Pharmacy, Helsinki University Hospital, Helsinki, Finland; 3Quality and ...
Ahtiainen HK   +4 more
doaj  

The Medical Record System at Okhaldhunga Community Hospital in Rural Nepal

open access: yes, 2011
Background Okhaldhunga Community Hospital (OCH) lies in a rural area in the east of Nepal. In this area there is no reliable power supply so it is still not possible for this hospital to use a computer based medical record system (MRS) like we do in most western hospitals today.
Skretting, Åge Aleksander   +1 more
openaire   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Norman Regional Health System: A City-Owned Public Trust Dedicated to Improving Performance [PDF]

open access: yes, 2010
Describes successful strategies for providing recommended treatment on process-of-care measures, including board and administration support, order sets, concurrent review, performance feedback, transparency, and engaging nurses.
Sharon Silow-Carroll
core  

Home - About - Disclaimer - Privacy